Calidi Biotherapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Calidi Biotherapeutics, Inc. (CLDI) had Deferred Tax Assets, Operating Loss Carryforwards of $25.92 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.92M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $20.22M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.24M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.10M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $0.00.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $25.92M 10-K · filed 2026-03-27 | |
| 2024-12-31 | $20.22M 10-K · filed 2026-03-27 | |
| 2023-12-31 | $15.24M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $10.10M 10-K · filed 2024-03-15 | $0.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $39.34K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |